European Archives - Page 13 of 1555 - European Medical Journal

AstraZeneca's HSCT-TMA drug misses main goal in latest trial

AstraZeneca's HSCT-TMA drug misses main endpoint

A phase 3 trial of ravulizumab fell short in adult HSCT-TMA patients, while paediatric results held more promise.

GLP 1 Receptor Agonists Linked to Hair Loss Risk

A target trial emulation found that glucagon like peptide 1 receptor agonists were associated with a higher risk of non scarring alopecia than two other diabetes drug classes.

Endometrial Immune Profile in Primary Infertility

Women with primary infertility demonstrated significantly higher endometrial levels of the proinflammatory cytokines IL-1β and IL-8 compared…

Gut-Oral Microbiome Changes Linked to Hand Osteoarthritis

A new study has found that oral microbiome dysbiosis and disrupted oral-gut microbial networks were associated with hand osteoarthritis.

Stevens Johnson Syndrome Risk Highest with Lamotrigine

A nationwide cohort quantified Stevens Johnson syndrome and toxic epidermal necrolysis risk after antiseizure medication initiation.

Innovation, Access, and Leadership in Cellular Therapy

Hema Now: Innovation, Access, and Leadership in Cellular Therapy

In this episode of Hema Now, Megan Melody speaks about the evolution of CAR-T cell therapy and its impact on lymphoma care…

Road Traffic Noise Linked to Higher Parkinson Disease Risk

A Danish cohort study of over 3 million people found road traffic noise was linked to a higher risk of Parkinson disease.

Expert Insights on the Management of Still’s Disease

The latest European Alliance of Associations for Rheumatology (EULAR)/ Paediatric Rheumatology European Society (PReS) recommendations on…

Bile Acid Metabolism Linked to Colorectal Cancer Prognosis

Bile acid metabolism suppression was linked to colorectal cancer prognosis and a 15 gene signature predicted overall survival.

Gastric Postbiotics Show Promise Against Biofilm Infections

Gastric microbiota-derived postbiotics demonstrated potent antimicrobial and anti-biofilm activity against Staphylococcus aureus and Candida albicans in vitro.